Ace the Anesthesia Knowledge Test 1 (AKT-1) 2026 – Dive Into Dreamy Success!

The use of vasopressin and methylene blue is effective in treating ACE inhibitor-associated refractory hypotension because both agents serve distinct but complementary roles in managing this condition.

Vasopressin is a potent vasoconstrictor that can help counteract hypotension by tightening blood vessels, thereby increasing systemic vascular resistance and blood pressure. This is particularly useful in scenarios where traditional catecholamines may not be sufficient due to the effects of ACE inhibitors, which can precipitate hypotension through altered angiotensin II production.

Methylene blue works by inhibiting nitric oxide synthase, leading to decreased levels of cyclic guanosine monophosphate (cGMP) in vascular smooth muscle cells. This decreases the vasodilatory effects driven by nitric oxide, which can be heightened in patients receiving ACE inhibitors. By reducing cGMP levels, methylene blue can help reverse the vasodilation associated with hypotension.

While intravenous fluids and increasing the rate of IV fluids can be initial supportive measures in managing hypotension, they may not be effective enough when the hypotension is refractory and caused specifically by the actions of ACE inhibitors. Corticosteroids are not indicated in this situation as they do not address the direct vascular mechanisms involved in the hypot